Skip to content
Search

Latest Stories

Fake Ozempic and Saxenda pens found in the UK

MHRA has seized the injections sold through ‘non-legitimate’ routes

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned the public to avoid buying pre-filled weight loss pens without a prescription.


The warning came after 369 fake Ozempic injections have been seized since January 2023.

However, Saxenda pens were obtained by members of the public in the UK through "non-legitimate routes".

The health regulator has urged the public to buy the pens after consulting a healthcare professional and with a prescription.

Dr Alison Cave, MHRA Chief Safety Officer shared her opinion on the matter, she said: “Buying products such as Ozempic or Saxenda without a prescription, from illegally trading suppliers, significantly increases the risk of receiving something which is either fake or not licensed for use in the UK.

“Products purchased in this way do not meet our strict quality and safety standards, and taking such medicines may put your health at significant risk.

She added: “We are advising all members of the public not to use any pre-filled weight loss pens they may have bought online and instead to report it to us so that we can investigate and take any necessary action.”

saxenda Saxenda is used for weight loss with diet and exercise. Credit: iStock

Since, the active pharmaceutical ingredient (API) found in the pens, Semaglutide and Liraglutide are prescription-only medicines.

The Ozempic is authorised in the UK for the treatment of adults with type 2 diabetes, while Saxenda is used for weight loss with diet and exercise.

However, Ozempic is commonly used off-label for weight loss in the UK.

Health Minister Will Quince said: “No one should put profit before the needs of patients, but fraudsters selling black market medicines like this are extremely dangerous and can put people’s health at risk.

“The medical advice is clear: patients should only use medicines like Ozempic or Saxenda where they’ve been prescribed it by a legitimate source, such as their GP or another legitimate prescriber.

“The MHRA have our full support in cracking down on these illegal online suppliers to ensure that patients are protected.”

MHRA confirmed that Ozempic had been found at two UK wholesalers on 18 October.

Last week, several Austrians were taken to the hospital after injecting fake Ozempic but the number of hospitalisations in the UK is still unknown.

Austria’s Federal Office for Safety in Health Care (BASG) confirmed that the patients have suffered hypoglycaemia shock, coma, and seizures.

It is believed that the injections contained insulin instead of the weight loss drug, semaglutide.

The surge in the sale of fake Ozempic has been flagged by the drug’s Danish manufacturer, Novo Nordisk.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less